Luttrell, Colleagues Move to Enshrine Trump's Psychedelic Therapy Order in Law, Protect Veterans' Access

WASHINGTON - Congressman Morgan Luttrell (R-TX), alongside Reps. Lou Correa (D-CA), Jack Bergman (R-MI), and Michael McCaul (R-TX), introduced the Initiating Biomedical Outcomes to Garner Advancements into Innovative Neuroplastogen Efficacy (IBOGAINE) Act. This legislation would codify President Donald J. Trump's Executive Order No. 14401, which accelerates the development of, and access to, psychedelic drugs that could save lives and reverse the crisis of serious mental illness in the United States.

"Last month, President Trump ushered in a new era of treatment options for our veterans with his executive order accelerating medical treatments for serious mental illness. Now we must codify it into law and ensure this progress is not lost," said Luttrell. "Psychedelic therapy has helped me and countless other veterans, improving our lives for the better. As we fight to combat our veteran suicide crisis, this breakthrough must be available to the men and women who served our nation."

"Our veterans and special operators have willingly put themselves in unimaginable danger to defend our freedoms," said McCaul. "We have a profound moral obligation to help these heroes heal from their wounds, both seen and unseen. As his executive order made clear, President Trump deeply understands our duty to care for them and the potential of treatments like Ibogaine to provide lasting healing. I'm proud to champion this legislation to cement the president's commitment to our veterans and look forward to our continued work in Congress to deliver for those who answered the call for us."

"Our veterans put their lives on the line to defend our country, and far too many come home with invisible wounds. They deserve access to every effective resource available to help treat PTSD and support their recovery. Psychedelic-assisted therapy has shown promising results, but we need more research and funding in order for this treatment to become a reality," said Correa."Representative General Jack Bergman and I have been tirelessly advocating for this issue in Congress, and President Trump's support has been a gamechanger for our effort. I am grateful to Rep. Morgan Luttrell for introducing legislation to cement Trump's executive order into law so the progress made does not get lost when a new administration comes into office."

"President Trump's Executive Order sent a strong and long-overdue message to the federal bureaucracy: the days of slow-walking progress are over," said Bergman. "Agencies now have clear direction from the top to move forward and deliver for our Veterans and families who have been waiting far too long. However, executive action alone is not enough. An Executive Order cannot rewrite federal law, and it can be reversed by a future administration. That's why I'm proud to support this legislation that codifies these directives into law and ensures lasting change. Congress must continue to act to streamline FDA approvals, address outdated restrictions, and guarantee the VA fully implements these policies so Veterans have access to the treatment options they deserve as soon as they become available."

Psychedelic treatments for veterans are currently unavailable in the United States. This has forced veterans suffering from PTSD and other mental health issues to travel overseas for assistance.

According to a study published by Stanford University School of Medicine in 2024, participants who received ibogaine treatment experienced reductions of 88% in PTSD symptoms, 87% in depression symptoms, and 81% in anxiety symptoms after just one month.

Read the full bill here.